Item 7.01 Regulation FD Disclosure.

Vincera Pharma, Inc. (the "Company") is furnishing the script attached hereto as Exhibit 99.1 for use on an investor call on January 5, 2021, in which the Company will discuss, among other things, its recently completed business combination and business updates.

The information in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act"), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.




(d) Exhibits.



                    Exhibit No.           Description

                    99.1^           Conference Call Script.




^   This Exhibit is furnished herewith and will not be deemed "filed" for
    purposes of Section 18 of the Exchange Act or deemed to be incorporated by
    reference into any filing under the Exchange Act or the Securities Act of
    1933 except to the extent that Vincera Pharma, Inc. specifically incorporates
    it by reference.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses